Screening compound: InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3

Screening compound: InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3
Screening compound: InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P664-0005

Molecular Formula

C18H20N6O2 (C18 H20 N6 O2)

Compound Name

1-(3-methoxybenzoyl)-4-{5-methyl-[1,2,4]triazolo[4,3-a]pyrimidin-7-yl}piperazine

IUPAC name

1-(3-methoxybenzoyl)-4-{5-methyl-[124]triazolo[43-a]pyrimidin-7-yl}piperazine

SMILES

Cc1cc(N(CC2)CCN2C(c2cc(OC)ccc2)=O)nc2nncn12

InChI

InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3

InChI Key

DIILCJRICJMNJF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27609941

InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3?
Check Price and Availability of InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H20N6O2/c1-13-10-16(20-18-21-19-12-24(13)18)22-6-8-23(9-7-22)17(25)14-4-3-5-15(11-14)26-2/h3-5,10-12H,6-9H2,1-2H3 available by request